Public, NASDAQ:TELK
NASDAQ Global Market
BUYINS.NET: SPIR, SYNO, TELK, TGE, TMWD, VLNC Have Also Been Removed From Naked Short List Today
Date: Fri, 29 Aug 2008 13:59:20 GMT
Tags:
BUYINS.NET: SPIR, SYNO, TELK, TGE, TMWD, VLNC Have Also Been Removed From Naked Short List Today
Trading Markets (press release) - Aug 29, 2008
Trading Markets (press release) - Aug 29, 2008
failing - to - deliver as of September 28 , 2007.WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling.Naked short selling ...
Telik's Proteasome Program Meets Preclinical Development Milestone
Date: Mon, 25 Aug 2008 14:48:51 GMT
Tags:
Telik's Proteasome Program Meets Preclinical Development Milestone
RedOrbit - Aug 25, 2008
RedOrbit - Aug 25, 2008
Telik has announced that its small molecule proteasome inhibitor program met a preclinical development milestone by demonstrating anticancer activity in preclinical models of human leukemia.The ...
Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
Date: Fri, 22 Aug 2008 12:25:39 GMT
Tags:
Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
PharmaLive.com (press release) - Aug 22, 2008
PharmaLive.com (press release) - Aug 22, 2008
PALO ALTO , Calif . , August 21 , 2008 / PRNewswire - FirstCall / - - Telik , Inc . announced today that the lead compounds of its Aurora kinase and VEGFR dual inhibitor program met a significant ...
Market Report -- In Play (TELK)
Date: Thu, 21 Aug 2008 21:28:04 GMT
Tags:
Market Report -- In Play (TELK)
MSN Money - Aug 21, 2008
MSN Money - Aug 21, 2008
Telik Proteasome Inhibitor Program meets a preclinical development milestone Co announces that its novel small molecule proteasome inhibitor program met a preclinical development milestone by ...
Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone
Date: Thu, 21 Aug 2008 20:17:23 GMT
Tags:
Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone
Earthtimes (press release) - Aug 21, 2008
Earthtimes (press release) - Aug 21, 2008
PALO ALTO , Calif . , Aug . 21 - - Telik , Inc . ( Nasdaq : TELK ) announced today that its novel small molecule proteasome inhibitor program met a preclinical development milestone by demonstrating ...
Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone - PR Newswire (press release)Telik, Inc. Q2 2008 Earnings Call Transcript (at Seeking Alpha)
Date: Tue, 2 Sep 2008 11:35:27 Etc/GMT
Tags:
Telik's Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone (PR Newswire)
Date: Thu, 21 Aug 2008 20:05:00 Etc/GMT
Tags:
Telik, Inc. announced today that the lead compounds of its Aurora kinase and VEGFR dual inhibitor program met a significant development milestone. Aurora kinase is a critical signaling enzyme whose function is required for cancer cell division, while vascular endothelial growth factor receptor plays a key role in tumor blood vessel formation, ensuring an adequate supply of nutrients to support tumor growth.
Telik's Proteasome Inhibitor Program Meets a Preclinical Development Milestone (PR Newswire)
Date: Thu, 21 Aug 2008 20:05:00 Etc/GMT
Tags:
Telik, Inc. announced today that its novel small molecule proteasome inhibitor program met a preclinical development milestone by demonstrating anticancer activity in preclinical models of human leukemia.
TELIK INC Financials (EDGAR Online Financials)
Date: Wed, 20 Aug 2008 13:04:30 Etc/GMT
Tags:
Telik, ReceptorBio sign diabetes license agreement (at bizjournals.com)
Date: Tue, 19 Aug 2008 13:45:07 Etc/GMT
Tags: